BioCentury
ARTICLE | Financial News

Intrexon raises $86M in follow-on

January 19, 2018 5:25 AM UTC

Synthetic biology company Intrexon Corp. (NYSE:XON) raised $86 million on through the sale of 6.9 million shares at $12.50 in a follow-on underwritten by JMP Securities, Stifel and Northland Capital M...

BCIQ Company Profiles

Precigen Inc.